PortfoliosLab logoPortfoliosLab logo
Claritev Corp (CTEV)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date
Apr 3, 2020

Highlights

Market Cap
$268.55M
Enterprise Value
$306.76M
EPS (TTM)
-$17.27
Total Revenue (TTM)
$965.41M
Gross Profit (TTM)
$535.54M
EBITDA (TTM)
$401.54M
Year Range
$12.04 - $74.07
Target Price
$33.00
ROA (TTM)
-5.82%
ROE (TTM)
163.47%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Claritev Corp

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Claritev Corp, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Claritev Corp (CTEV) has returned -61.78% so far this year and -20.79% over the past 12 months.


Claritev Corp

1D
3.35%
1M
21.31%
YTD
-61.78%
6M
-69.22%
1Y
-20.79%
3Y*
-27.23%
5Y*
-41.42%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Apr 3, 2020, CTEV's average daily return is -0.02%, while the average monthly return is -1.12%.

Historically, 44% of months were positive and 56% were negative. The best month was Dec 2024 with a return of +87.3%, while the worst month was Feb 2026 at -50.4%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.

On a daily basis, CTEV closed higher 46% of trading days. The best single day was Dec 24, 2024 with a return of +94.9%, while the worst single day was Feb 24, 2026 at -41.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-36.47%-50.41%21.31%-61.78%
202523.55%14.95%-1.72%8.73%71.42%17.37%-11.66%72.84%-22.97%22.65%-16.94%-20.94%189.24%
2024-29.86%10.89%-27.57%-19.90%-17.37%-27.66%15.89%-47.79%-18.72%17.28%-11.94%87.33%-74.34%
202314.78%-23.48%4.95%-7.71%42.08%51.80%1.90%-20.47%-1.75%0.60%-23.08%10.77%25.22%
2022-9.03%-6.70%24.47%-5.34%12.87%9.80%-7.83%-30.43%-18.75%0.35%-48.08%-22.82%-74.04%
2021-0.13%-10.90%-21.94%33.87%13.59%12.80%-15.44%-25.47%-6.17%-23.45%-6.26%9.65%-44.56%

Benchmark Metrics

Claritev Corp has an annualized alpha of -22.22%, beta of 1.12, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since April 06, 2020.

  • This stock participated in 170.84% of S&P 500 Index downside but only -40.54% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-22.22%
Beta
1.12
0.04
Upside Capture
-40.54%
Downside Capture
170.84%

Return for Risk

Risk / Return Rank

CTEV ranks 35 for risk / return — below 35% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


CTEV Risk / Return Rank: 3535
Overall Rank
CTEV Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
CTEV Sortino Ratio Rank: 4040
Sortino Ratio Rank
CTEV Omega Ratio Rank: 4141
Omega Ratio Rank
CTEV Calmar Ratio Rank: 3333
Calmar Ratio Rank
CTEV Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Claritev Corp (CTEV) and compare them to a chosen benchmark (S&P 500 Index).


CTEVBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.20

0.90

-1.10

Sortino ratio

Return per unit of downside risk

0.45

1.39

-0.93

Omega ratio

Gain probability vs. loss probability

1.07

1.21

-0.15

Calmar ratio

Return relative to maximum drawdown

-0.26

1.40

-1.66

Martin ratio

Return relative to average drawdown

-0.55

6.61

-7.15

Explore CTEV risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Claritev Corp doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Claritev Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Claritev Corp was 98.91%, occurring on Nov 19, 2024. The portfolio has not yet recovered.

The current Claritev Corp drawdown is 96.59%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.91%Jul 20, 20201093Nov 19, 2024
-2.74%Jul 6, 20203Jul 8, 20203Jul 13, 20206
-2.23%Jun 11, 20203Jun 15, 20206Jun 23, 20209
-1.76%May 13, 20201May 13, 202010May 28, 202011
-1.6%Jun 24, 20203Jun 26, 20202Jun 30, 20205

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Claritev Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Claritev Corp is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CTEV relative to other companies in the Health Information Services industry. Currently, CTEV has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items